# C_2007075EN.01001401.xml

| 3.4.2007 | EN | Official Journal of the European Union | C 75/14 |
| --- | --- | --- | --- |

3.4.2007

EN

Official Journal of the European Union

C 75/14

---

Prior notification of a concentration

(Case COMP/M.4638 — CERP/Sanacorp/Millenium JV)

Candidate case for simplified procedure

(Text with EEA relevance)

(2007/C 75/09)

| 1. | On 29 March 2007, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertakings CERP Rouen S.A. (‘CERP Rouen’, France) and Sanacorp Pharmahandel AG (‘Sanacorp’, Germany) acquire within the meaning of Article 3(1)(b) of the Council Regulation joint control of a newly created company constituting a joint venture (‘Millennium’) by means of contribution of assets and activities. |
| --- | --- |

1.

On 29 March 2007, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertakings CERP Rouen S.A. (‘CERP Rouen’, France) and Sanacorp Pharmahandel AG (‘Sanacorp’, Germany) acquire within the meaning of Article 3(1)(b) of the Council Regulation joint control of a newly created company constituting a joint venture (‘Millennium’) by means of contribution of assets and activities.

1

| 2. | The business activities of the undertakings concerned are:






  — | for CERP Rouen: wholesale of pharmaceuticals and related services in France and Belgium; supply of home-care equipment, IT services and financing to pharmacies; |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for CERP Rouen: wholesale of pharmaceuticals and related services in France and Belgium; supply of home-care equipment, IT services and financing to pharmacies;

| — | for Sanacorp: wholesale of pharmaceuticals and related services in Germany; |
| --- | --- |

—

for Sanacorp: wholesale of pharmaceuticals and related services in Germany;

| — | for Millennium: combination of the parent companies' activities in the wholesale of pharmaceuticals and related services in France, Belgium and Germany. |
| --- | --- |

—

for Millennium: combination of the parent companies' activities in the wholesale of pharmaceuticals and related services in France, Belgium and Germany.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

2

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4638 — CERP/Sanacorp/Millenium JV, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| J-70 |
| B-1049 Bruxelles/Brussel |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4638 — CERP/Sanacorp/Millenium JV, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

B-1049 Bruxelles/Brussel

---

(1)  OJ L 24, 29.1.2004, p. 1.

1

(2)  OJ C 56, 5.3.2005, p. 32.

2

---